These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19933496)

  • 21. The SIST-M: predictive validity of a brief structured clinical dementia rating interview.
    Okereke OI; Pantoja-Galicia N; Copeland M; Hyman BT; Wanggaard T; Albert MS; Betensky RA; Blacker D
    Alzheimer Dis Assoc Disord; 2012; 26(3):225-31. PubMed ID: 21986342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia.
    Fernandes A; Tábuas-Pereira M; Duro D; Lima M; Gens H; Santiago B; Durães J; Almeida MR; Leitão MJ; Baldeiras I; Santana I
    Exp Gerontol; 2020 Sep; 138():111004. PubMed ID: 32561398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer's disease.
    Lepara O; Alajbegovic A; Zaciragic A; Nakas-Icindic E; Valjevac A; Lepara D; Hadzovic-Dzuvo A; Fajkic A; Kulo A; Sofic E
    J Neural Transm (Vienna); 2009 Dec; 116(12):1651-6. PubMed ID: 19809863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.
    Haaksma ML; Calderón-Larrañaga A; Olde Rikkert MGM; Melis RJF; Leoutsakos JS
    Int J Geriatr Psychiatry; 2018 Aug; 33(8):1057-1064. PubMed ID: 29761569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-Reactive Protein Can Be an Early Predictor of Poststroke Apathy in Acute Ischemic Stroke Patients.
    Chen L; Xiong S; Liu Y; Lin M; Wang J; Zhong R; Zhao J; Liu W; Zhu L; Shang X
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1861-1869. PubMed ID: 29548857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of education on very mild dementia among Chinese people in Hong Kong: potential mediators in the Cantonese Mini-Mental State Examination tasks.
    Tse CS; Chang JF; Leung GT; Fung AW; Hau KT; Chiu HF; Lam LC
    Aging Ment Health; 2013; 17(3):310-8. PubMed ID: 23176680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).
    Oh ES; Rosenberg PB; Rattinger GB; Stuart EA; Lyketsos CG; Leoutsakos JS
    J Am Geriatr Soc; 2021 Apr; 69(4):955-963. PubMed ID: 33382921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
    Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
    JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.
    van Himbergen TM; Beiser AS; Ai M; Seshadri S; Otokozawa S; Au R; Thongtang N; Wolf PA; Schaefer EJ
    Arch Neurol; 2012 May; 69(5):594-600. PubMed ID: 22213409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum C-reactive protein concentration in Bosnian patients with probable Alzheimer's disease.
    Zaciragic A; Lepara O; Valjevac A; Arslanagic S; Fajkic A; Hadzovic-Dzuvo A; Avdagic N; Alajbegovic A; Mehmedika-Suljic E; Coric G
    J Alzheimers Dis; 2007 Sep; 12(2):151-6. PubMed ID: 17917159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional assessment staging (FAST) in Korean patients with Alzheimer's disease.
    Na HR; Kim SY; Chang YH; Park MH; Cho ST; Han IW; Kim TY; Hwang SA
    J Alzheimers Dis; 2010; 22(1):151-8. PubMed ID: 20847407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using a Rasch scale to characterize the clinical features of patients with a clinical diagnosis of uncertain, probable, or possible Alzheimer disease at intake.
    Hughes LF; Perkins K; Wright BD; Westrick H
    J Alzheimers Dis; 2003 Oct; 5(5):367-73. PubMed ID: 14646027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of the Brazilian version of the CDR scale in samples of dementia patients].
    Maia AL; Godinho C; Ferreira ED; Almeida V; Schuh A; Kaye J; Chaves ML
    Arq Neuropsiquiatr; 2006 Jun; 64(2B):485-9. PubMed ID: 16917624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
    Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
    J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the time to clinically worsening in mild cognitive impairment patients and its utility in clinical trial design by modeling a longitudinal clinical dementia rating sum of boxes from the ADNI database.
    Ito K; Hutmacher MM
    J Alzheimers Dis; 2014; 40(4):967-79. PubMed ID: 24531162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.
    Tao Q; Ang TFA; DeCarli C; Auerbach SH; Devine S; Stein TD; Zhang X; Massaro J; Au R; Qiu WQ
    JAMA Netw Open; 2018 Oct; 1(6):e183597. PubMed ID: 30646251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.